Showing results (1181-1190 of 3,178) with videos related to

Sort By:
Pageof 318
Translational Oncology|March 24, 2022
Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathwayKaushik Neogi, Prashant R Murumkar, Priyanshu Sharma, et al.
Translational Oncology|March 26, 2022
Stabilization of Notch1 and β-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasisShuxuan Zhu, Xiaoyu Wang, Lei Liu, et al.
Translational Oncology|April 1, 2022
Tebentafusp in first-line melanoma trials: An outperforming outlierTimothée Olivier, Vinay Prasad
Translational Oncology|April 1, 2022
cGAS-STING signalings potentiate tumor progression via sustaining cancer stemnessFu-Rao Liu, Ming-Jie Jiang, Zhu Mei, et al.
Translational Oncology|September 15, 2018
Clinical Validation of Automatable Gaussian Normalized CBV in Brain Tumor Analysis: Superior Reproducibility and Slightly Better Association with Survival than Current Standard Manual Normal Appearing White Matter NormalizationLei Qin, Xiang Li, Angie Li, et al.
Translational Oncology|May 5, 2019
Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated SignalingLi Zhang, Anand Singh, Christopher Plaisier, et al.
Translational Oncology|September 22, 2018
Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot StudyAlexey Surov, Hans Jonas Meyer, Anne Kathrin Höhn, et al.
Translational Oncology|June 28, 2017
The Potential Value of Preoperative MRI Texture and Shape Analysis in Grading Meningiomas: A Preliminary InvestigationPeng-Fei Yan, Ling Yan, Ting-Ting Hu, et al.
Translational Oncology|June 29, 2017
The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine FactorsLouisa Bolm, Simon Cigolla, Uwe A Wittel, et al.
Translational Oncology|July 1, 2017
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant ChemotherapyEleni Timotheadou, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.
Pageof 318